Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05MDB
|
|||
| Former ID |
DNC008271
|
|||
| Drug Name |
N,N-dimethyl-2,2,2-triphenylacetamide
|
|||
| Synonyms |
N,N-Dimethyl-2,2,2-triphenylacetamide; AC1LDGNY; N,N-Dimethyl-triphenylacetamide; JGBIXOAQARJTNI-UHFFFAOYSA-N; N,N-Dimethyl-2,2,2-triphenylacetamide #; Acetamide, N,N-dimethyl-2,2,2-triphenyl-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H21NO
|
|||
| Canonical SMILES |
CN(C)C(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
|
|||
| InChI |
1S/C22H21NO/c1-23(2)21(24)22(18-12-6-3-7-13-18,19-14-8-4-9-15-19)20-16-10-5-11-17-20/h3-17H,1-2H3
|
|||
| InChIKey |
JGBIXOAQARJTNI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Calcium-activated potassium channel (KCN) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. J Med Chem. 2008 Feb 28;51(4):976-82. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.